Shanghai Shyndec Pharmaceutical Co Ltd (600420) — Free Cash Flow Generation Index
Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Free Cash Flow Generation Index of 0.86x as of September 2025. Free cash flow of CN¥418.93 Million represents 1% of operating cash flow (CN¥486.04 Million). Read Shanghai Shyndec Pharmaceutical Co Ltd total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shanghai Shyndec Pharmaceutical Co Ltd Free Cash Flow Generation Index (2004–2025)
Historical FCF Generation Index trend for Shanghai Shyndec Pharmaceutical Co Ltd across 22 annual periods. Explore Shanghai Shyndec Pharmaceutical Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Shanghai Shyndec Pharmaceutical Co Ltd (2004–2025)
Year-by-year Free Cash Flow Generation Index for Shanghai Shyndec Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 600420 company net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.84x | CN¥1.43 Billion | CN¥1.70 Billion | CN¥263.83 Million | ▼ -6.4% |
| 2024 | 0.90x | CN¥2.04 Billion | CN¥2.26 Billion | CN¥219.77 Million | ▲ +13.9% |
| 2023 | 0.79x | CN¥1.36 Billion | CN¥1.72 Billion | CN¥357.19 Million | ▼ -11.2% |
| 2022 | 0.89x | CN¥2.55 Billion | CN¥2.86 Billion | CN¥307.44 Million | ▲ +29.4% |
| 2021 | 0.69x | CN¥1.16 Billion | CN¥1.68 Billion | CN¥521.44 Million | ▼ -9.0% |
| 2020 | 0.76x | CN¥1.18 Billion | CN¥1.56 Billion | CN¥377.98 Million | ▲ +11.1% |
| 2019 | 0.68x | CN¥866.32 Million | CN¥1.27 Billion | CN¥403.82 Million | ▼ -10.3% |
| 2018 | 0.76x | CN¥1.27 Billion | CN¥1.67 Billion | CN¥399.40 Million | ▼ -18.0% |
| 2017 | 0.93x | CN¥2.15 Billion | CN¥2.31 Billion | CN¥168.44 Million | ▲ +30.2% |
| 2016 | 0.71x | CN¥597.27 Million | CN¥838.58 Million | CN¥241.30 Million | ▲ +2150.6% |
| 2015 | -0.03x | CN¥-7.87 Million | CN¥226.65 Million | CN¥234.52 Million | ▲ +94.8% |
| 2014 | -0.67x | CN¥-172.02 Million | CN¥258.51 Million | CN¥430.53 Million | ▲ +54.8% |
| 2013 | -1.47x | CN¥-305.13 Million | CN¥207.50 Million | CN¥512.62 Million | ▼ -34.1% |
| 2012 | -1.10x | CN¥-212.11 Million | CN¥193.41 Million | CN¥405.52 Million | ▼ -2033.3% |
| 2011 | 0.06x | CN¥7.72 Million | CN¥136.12 Million | CN¥128.40 Million | ▲ +116.0% |
| 2010 | -0.36x | CN¥-40.91 Million | CN¥115.11 Million | CN¥156.02 Million | ▼ -152.4% |
| 2009 | 0.68x | CN¥66.14 Million | CN¥97.43 Million | CN¥31.29 Million | ▼ -11.4% |
| 2008 | 0.77x | CN¥44.49 Million | CN¥58.04 Million | CN¥13.56 Million | ▲ +31.8% |
| 2007 | 0.58x | CN¥47.86 Million | CN¥82.31 Million | CN¥34.45 Million | ▲ +268.9% |
| 2006 | 0.16x | CN¥11.60 Million | CN¥73.60 Million | CN¥62.00 Million | ▲ +166.4% |
| 2005 | -0.24x | CN¥-13.75 Million | CN¥57.90 Million | CN¥71.65 Million | ▼ -429.2% |
| 2004 | 0.07x | CN¥1.23 Million | CN¥17.02 Million | CN¥15.79 Million | — |